€
0. 01
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
10,000 Volume
- Eps
€ 0.01
Previous Close Want to track ICL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cell Impact AB (publ) (ICL) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.77M
Trailing P/E (ttm) -0.03
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.05
Enterprise Value/Revenue 2.83
Enterprise Value/EBITDA -0.29
Overview
Shares outstanding 487.23M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 500
Average volume (90 days) 5.49K
Price summary
52-Week low 0
52-Week high 0.05
Beta -
50-Day moving average 0.02
200-Day moving average 0.02
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 25 Aug 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.91%
Operating margin -22.9%
Operational effectiveness
Return on assets -0.81%
Return on equity -1.09%
Income Statement
Revenue (ttm) 5.57M
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) 0.99%
Gross profit (ttm) -5.09M
EBITDA -
Net income to common (ttm) -131.98M
Diluted EPS (ttm) -0.65
Quarterly earnings growth (yoy) 0.12%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 14.87M
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 3.06%
Book value per share (mrq) 0.35
Cash Flow
Cash flow statement -48.15M
Levered free cash flow (LFCF) -131.98M
